Linee di indirizzo AMD-SID sulla nutrizione nella gravidanza fisiologica o complicata da obesità e/o diabete Share Post navigation Safety, pharmacokinetics and pharmacodynamics of HRS‐7535, a novel oral small molecule glucagon‐like peptide‐1 receptor agonist, in healthy participants: A phase 1, randomized, double‐blind, placebo‐controlled, single‐ and multiple‐ascending dose, and food effect trialAdvancing type 2 diabetes therapy with iGlarLixi in older people: Pooled analysis of four randomized controlled trials
